Fantastic Voyage Through Cardiology: From 1969 to 2008  by Mensah, George A.
F
C
H
2
A
i
d
p
t
s
i
e
t
(
p
c
t
e
s
r
a
H
g
d
c
i
o
w
t
d
b
o
*
*
H
C
M
4
A
E
P
n
P
Journal of the American College of Cardiology Vol. 53, No. 23, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
Published by Elsevier Inc.CORRESPONDENCELetters to the Editor
R
1
2
3
4
5
6
7
8
R
W
c
g
b
d
a
1
2
3
4antastic Voyage Through
ardiology: From 1969 to 2008
echt and Colmer (1) deserve praise for their fantastic account of
generations of cardiology encompassed in 1 still-living patient.
s I reviewed their wonderful presentation of historical text,
mages, and videos, I could not help but reminisce about the joy of
iscovering, as a medical student, the numerous interventions
ossible in cardiology practice. During my cardiology fellowship
raining, publication of Waller’s (2) account of “crackers, breakers,
tretchers, drillers, scrapers, shavers, burners, welders and melters”
n the future treatment of coronary artery disease only added to the
xcitement about the specialty.
In my old age, however, I have become equally impressed with
he power of public health measures and the impact of prevention
3,4). Aspirin, beta-blockers, statins, and the control of blood
ressure and cholesterol play a crucial role in reducing cardiovas-
ular morbidity and mortality (4). Similarly, policy-based initia-
ives (4,5) and other public health measures that reduce population
xposure to risk factors or support health-improving behaviors,
uch as smoking cessation, increased physical activity, and a diet
ich in fruits and vegetables, play important roles, although they
re by no means as glamorous as the interventions described by
echt and Colmer (1) or chronicled by Waller (2).
Several studies from the U.S., New Zealand, Scotland, En-
land, Wales, Ireland, and Finland suggest that 45% to 75% of the
ecline in coronary mortality can be attributed to risk factor
hanges, and the remaining 25% to 55% to treatments (6). In fact,
mproved risk factor levels explained 53% to 72% (and treatments
nly 23%) of the decline in coronary mortality in Finland (7). It
ould be highly instructive to learn from Hecht and Colmer how
he spectrum of risk factors and major preventive practices changed
uring this fantastic voyage. In the words of the legendary
roadcaster, Paul Harvey, providing this account may tell “the rest
f the story” (8).
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eply
e are delighted to respond to Dr. Mensah’s query regarding the
hanges in risk factors and major preventive practices during the 2
enerations of the “fantastic voyage” (1). Sadly, there is a large gap
etween progress in prevention and the spectacular progress in
iagnostic testing and intervention. This prevention gap may be
ttributed to several factors:
. In primary prevention, there is a disconnect between risk
assessment by risk factor analysis (Framingham Risk Score,
Procam, European Society of Cardiology) and the actual risk
determined by events, which is much more accurately predicted
by coronary calcium scanning (2,3).
. Despite the superiority of coronary calcium scanning to identify
candidates for aggressive prevention, its widespread use for
screening has been road-blocked by demands for randomized
controlled trials showing its effect on outcomes. This criterion
has never been fulfilled by the Framingham Risk Score,
Procam, European Society of Cardiology, or, for that matter, by
nuclear stress testing, rest and stress echocardiography, cardiac
catheterization, and most interventions. Nonetheless, they are
accepted as gospel.
. This “deadly double standard” (4) and the continued reliance
on risk-factor-based prognostication will continue to deprive
high-risk patients of the possibility of early identification,
with an unconscionable and unnecessary increased morbidity
and mortality.
. Indeed, there has been an explosion of risk factor identification
(including high-sensitivity C-reactive protein), none of which
